NO841627L - Fremgangsmaate for fremstilling av hydantoinderivater - Google Patents
Fremgangsmaate for fremstilling av hydantoinderivaterInfo
- Publication number
- NO841627L NO841627L NO841627A NO841627A NO841627L NO 841627 L NO841627 L NO 841627L NO 841627 A NO841627 A NO 841627A NO 841627 A NO841627 A NO 841627A NO 841627 L NO841627 L NO 841627L
- Authority
- NO
- Norway
- Prior art keywords
- spiro
- fluoro
- dione
- tritium
- imidazolidine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/96—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings spiro-condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- General Chemical & Material Sciences (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/488,947 US4474967A (en) | 1983-04-27 | 1983-04-27 | 8-Deutero and 8-tritio-substituted derivatives of D-4S-6-fluoro-spiro-[chroman-4,4'-imidazolidine]-2',5'-dione |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO841627L true NO841627L (no) | 1984-10-29 |
Family
ID=23941785
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO841627A NO841627L (no) | 1983-04-27 | 1984-04-25 | Fremgangsmaate for fremstilling av hydantoinderivater |
Country Status (22)
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0172719B1 (en) * | 1984-08-20 | 1988-09-21 | Pfizer Inc. | Process for the production as asymmetric hydantoins |
| US4841079A (en) * | 1987-08-07 | 1989-06-20 | Pfizer, Inc. | Process for the production of asymmetric hydantoins |
| US5059693A (en) * | 1989-10-06 | 1991-10-22 | Pfizer Inc. | Process for making 3-aroyl-2-oxindole-1-carboxamides |
| GB9317764D0 (en) * | 1993-08-26 | 1993-10-13 | Pfizer Ltd | Therapeutic compound |
| CN1295476A (zh) * | 1998-01-30 | 2001-05-16 | 株式会社·R-技术上野 | 眼用组合物 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3821383A (en) * | 1972-07-10 | 1974-06-28 | Ayerst Mckenna & Harrison | Compositions for and a method of treating diabetic complications |
| US4117230A (en) * | 1976-10-18 | 1978-09-26 | Pfizer Inc. | Hydantoin derivatives as therapeutic agents |
| CA1088945A (en) * | 1976-10-18 | 1980-11-04 | Pfizer Limited | Hydantoin derivatives as therapeutic agents |
| US4130714A (en) * | 1977-05-23 | 1978-12-19 | Pfizer Inc. | Hydantoin therapeutic agents |
| US4248882A (en) * | 1980-02-12 | 1981-02-03 | Pfizer Inc. | Treating diabetes-associated complications with hydantoin amines |
| JPS5745185A (en) * | 1980-07-21 | 1982-03-13 | Eisai Co Ltd | Hydantoin derivative and its preparation |
-
1983
- 1983-04-27 US US06/488,947 patent/US4474967A/en not_active Expired - Fee Related
-
1984
- 1984-04-19 EP EP84302667A patent/EP0124327A3/en not_active Withdrawn
- 1984-04-24 DD DD84262257A patent/DD219772A5/de not_active IP Right Cessation
- 1984-04-24 PL PL1984247379A patent/PL142759B1/pl unknown
- 1984-04-24 PT PT78476A patent/PT78476B/pt unknown
- 1984-04-25 ES ES531873A patent/ES8607312A1/es not_active Expired
- 1984-04-25 SU SU843732823A patent/SU1240362A3/ru active
- 1984-04-25 NO NO841627A patent/NO841627L/no unknown
- 1984-04-25 CA CA000452774A patent/CA1226866A/en not_active Expired
- 1984-04-26 IL IL71656A patent/IL71656A/xx not_active IP Right Cessation
- 1984-04-26 ZA ZA843091A patent/ZA843091B/xx unknown
- 1984-04-26 DK DK208284A patent/DK208284A/da not_active Application Discontinuation
- 1984-04-26 KR KR1019840002240A patent/KR860000915B1/ko not_active Expired
- 1984-04-26 HU HU841622A patent/HU191755B/hu not_active IP Right Cessation
- 1984-04-26 PH PH30605A patent/PH22869A/en unknown
- 1984-04-26 FI FI841657A patent/FI841657A7/fi not_active Application Discontinuation
- 1984-04-26 AU AU27263/84A patent/AU542142B2/en not_active Ceased
- 1984-04-26 NZ NZ207959A patent/NZ207959A/en unknown
- 1984-04-26 GR GR74517A patent/GR81491B/el unknown
- 1984-04-26 YU YU741/84A patent/YU43358B/xx unknown
- 1984-04-26 CS CS843101A patent/CS250661B2/cs unknown
- 1984-04-27 JP JP59086040A patent/JPS59205384A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| DK208284A (da) | 1984-10-28 |
| EP0124327A2 (en) | 1984-11-07 |
| HUT34197A (en) | 1985-02-28 |
| US4474967A (en) | 1984-10-02 |
| FI841657A0 (fi) | 1984-04-26 |
| JPS59205384A (ja) | 1984-11-20 |
| YU43358B (en) | 1989-06-30 |
| SU1240362A3 (ru) | 1986-06-23 |
| EP0124327A3 (en) | 1985-07-31 |
| IL71656A0 (en) | 1984-07-31 |
| IL71656A (en) | 1987-10-20 |
| AU542142B2 (en) | 1985-02-07 |
| CA1226866A (en) | 1987-09-15 |
| ES8607312A1 (es) | 1986-06-01 |
| PH22869A (en) | 1989-01-19 |
| NZ207959A (en) | 1987-04-30 |
| KR840008355A (ko) | 1984-12-14 |
| PT78476A (en) | 1984-05-01 |
| KR860000915B1 (ko) | 1986-07-18 |
| FI841657L (fi) | 1984-10-28 |
| GR81491B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1984-12-11 |
| ZA843091B (en) | 1985-12-24 |
| DD219772A5 (de) | 1985-03-13 |
| DK208284D0 (da) | 1984-04-26 |
| HU191755B (en) | 1987-04-28 |
| PL247379A1 (en) | 1985-03-26 |
| ES531873A0 (es) | 1986-06-01 |
| PL142759B1 (en) | 1987-11-30 |
| CS250661B2 (en) | 1987-05-14 |
| YU74184A (en) | 1986-10-31 |
| AU2726384A (en) | 1984-11-01 |
| FI841657A7 (fi) | 1984-10-28 |
| PT78476B (en) | 1986-08-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA1088073A (en) | Hydantoin therapeutic agents | |
| NO167947B (no) | Lagringsanordning for baand- eller plate-registreringsmedier | |
| US4248882A (en) | Treating diabetes-associated complications with hydantoin amines | |
| NO168302B (no) | Fremgangsmaate for fremstilling av krystallform (b) av 2-etoksy-4-(n-(1-(2-piperidino-fenyl)-3-metyl-1-butyl)-aminokarbonylmetyl)-benzoesyre | |
| Deliwala et al. | Further studies in substituted 4H-1, 2, 4-triazoles for possible hypoglycemic activity | |
| NO173938B (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrido-pyridazinon-eddiksyrer | |
| NO841627L (no) | Fremgangsmaate for fremstilling av hydantoinderivater | |
| NO773300L (no) | Fremgangsmaate for fremstilling av nye eddiksyrederivater | |
| EP0127412B1 (en) | Imidazolidinedione derivatives | |
| KR860000486B1 (ko) | 옥사졸리딘디온 유도체의 제조 방법 | |
| NO309563B1 (no) | Benzensulfonamidforbindelser, deres fremstilling samt medikament og farmasöytisk preparat inneholdende disse | |
| US5120759A (en) | Tetrahydronaphthalene derivatives for improving short-term memory | |
| EP0028485B1 (en) | Spiro-imidazolones for alleviating diabetes-associated conditions, processes for preparing them, and pharmaceutical compositions containing them | |
| NZ192650A (en) | Spiro-quinolylhydantoins;anti-diabetic agents | |
| EP0168181B1 (en) | Cyclic amides | |
| US4177282A (en) | Hydantoin therapeutic agents | |
| US4730059A (en) | 6'-thiomethylsubstituted spectinomycins | |
| NO169588B (no) | Analogifremgangsmaate for fremstilling av nye, terapeutiskaktive aryloxycycloalkanol-aminoalkylenarylketoner | |
| AU594686B2 (en) | Process for the preparation of 2-halonicergoline derivatives and their acid addition salts and new 2-halonicergolines | |
| US4533667A (en) | Imidazolidinedione derivatives | |
| CS273186B2 (en) | Method of spiroimidazolidinedione production | |
| GB2152052A (en) | Hexahydroazepino(3,4-d)imidazole derivatives | |
| KR820001930B1 (ko) | 프탈라진-4-일아세트산 유도체의 제조방법 | |
| NO152750B (no) | Fremgangsmaate for fremstilling av nitrogen brohode-kondenserte pyrimidinforbindelser | |
| Battersby et al. | Biosynthesis of porphyrins and related macrocycles. Part 12. Vitamin B 12: studies with 1-methylbilanes |